Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
KNR Constructions up 3% on sanction letters from banks for 3 projects

2018-07-09 moneycontrol
The shares of KNR Constructions gained 3 percent in intraday Monday following the receipt of sanction letters from banks to finance their projects.
KNRCON 532942

0
KNR Constructions Limited - Updates

2018-07-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KNRCON 532942

0
Why road-construction stocks are struggling

2018-07-08 premium.thehindubusinessline
Till recently, stocks in the road construction space had enjoyed a good run on the bourses, all thanks to the healthy award of contracts by the National Highways Authority of India (NHAI), which ensured revenue visibility for many companies, at least for the next couple of years.
KNRCON SADBHAV 532942 532710

23
Closing Bell: Sensex loses 115 pts, Nifty ends below 10,750; ITC, LT shares drag

2018-06-21 moneycontrol
Global Update: Asian markets closed mixed as investors monitor trade developments between world's largest economies US and China. China's Shanghai Composite, Hong Kong's Hang Seng and South Korea's Kospi closed down over a percent while Japan's Nikkei gained 0.6 percent and Australia's ASX 200 rose 1 percent.
INDIANB 500325 533096 RELIANCE IDBI 512573 532814 532832 533278 JUSTDIAL 535648 RIGD HDFCBANK CLNDY RLNIY UBNC 500116 AVANTI 534690 IBN 532942 539207 KNRCON ICICIBANK LAKSHVILAS HDB 532174 500180 ADANIPOWER COALINDIA JSTQY MANPASAND IBREALEST

16
Market Live: Sensex falls 100 pts, Nifty below 10,750; crude dips 2% ahead of OPEC meet

2018-06-21 moneycontrol
Further, reports of the bank appointing a law firm and risk assessment company to assist the independent enquiry against its CEO soothed market investors.
500325 534690 IBN RELIANCE 532942 539207 KNRCON ICICIBANK LAKSHVILAS HDB 532174 500180 RIGD HDFCBANK MANPASAND RLNIY

16
Market Live: Midcap underperforms Sensex; Brent crude dips 1% ahead of OPEC meet

2018-06-21 moneycontrol
Oil prices dipped as Iran signaled it could be won over to a small rise in OPEC crude output, likely paving the road for the producer cartel to agree on a supply increase during a meeting on June 22.
INDIGO 500325 534690 IBN RELIANCE 532942 539448 539207 KNRCON ICICIBANK LAKSHVILAS HDB 532174 500180 RIGD HDFCBANK MANPASAND RLNIY

21
Market Live: Nifty struggles below 10,800; Jhunjhunwala says 2018 is the year of consolidation

2018-06-21 moneycontrol
KNR in focus: In a clarification note to the exchanges regarding "Promoters of Company taking large interest free loan from the Company", KNR Constructions said the promoters have extended unsecured loan of Rs 214.08 crore to the company, at the interest rate of 8.45 percent per annum to defray the term loan of one of the SPV. "There are no loans and advances given by the Company to promoters."
OPTOCIRCUI 500325 RELIANCE IDBI 539254 533155 JUBLFOOD 511288 CMQMY RIGD JBLWY CUMMINSIND HDFCBANK 500378 RLNIY SBAZ ADANITRANS GRUH INDIGO 500116 534690 IBN GRHFY 532942 539207 539448 KNRCON 500480 ICICIBANK LAKSHVILAS HDB 532174 500180 JINDALSAW 532391 MANPASAND

0
KNR Constructions Limited - Updates

2018-06-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KNRCON 532942

0
KNR Constructions (Buy)

2018-06-20 thehindubusinessline
Post the strong order inflow of ₹4,500 crore in Q4FY18 order book of KNR Constructions is standing at ₹6,793 crore which is 3.5x of TTM EPC revenue. Despite the strong order book, revenue growth may see a dip in H1FY19 due to couple of slow moving projects and new orders which will take time to translate into revenues. However, we believe strong revenue growth in FY20 as the execution of newly won HAM projects will pick up.
KNRCON 532942

0
KNR Constructions Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KNRCON 532942

0
KNR Constructions Limited - Investor Presentation

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KNRCON 532942

0
KNR Constructions Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KNRCON 532942

0
KNR Constructions Limited - Updates

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KNRCON 532942

0
KNR Constructions Limited - Financial Result Updates

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KNRCON 532942

0
KNR Constructions Limited - Trading Window

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KNRCON 532942

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...